GlobeNewswire

Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® (toripalimab-tpzi) in Squamous Cell Anal Carcinoma
11/11/2026
Pelareorep and toripalimab combine potentially complementary mechanisms designed to enhance antitumor immune responses and help overcome tumor immune resistance Study may represent a first step toward evaluating the [...]
Amlogenyx to Participate in 2026 Jefferies Global Healthcare Conference
11/11/2026
NOVATO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Amlogenyx, Inc., a biotechnology company focused on developing gene therapies for Alzheimer’s disease and other neurodegenerative diseases, today announced members of [...]
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
11/11/2026
LONDON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference in [...]
Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business Update
11/11/2026
Gamgertamig poster accepted for presentation at the 2026 ASH 1 Annual Meeting, featuring data from ongoing Phase 1b studies that suggest potential to retain remission after B cell reconstitution, maintained in the [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
11/11/2026
Company Announcement COPENHAGEN, Denmark; November 11, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Maxim Hair Restoration Partners With TrichoLAB to Bring 3D Planning to Its Hair Transplant Consultations
11/11/2026
Through the partnership, patients at select Maxim Hair Restoration clinics can now see a 3D preview of their planned hairline and graft placement before surgery, using TrichoLAB's 3D Studio and 3D Transplanner [...]
PETVIVO HOLDINGS TO FILE QUARTERLY REPORT ON NOVEMBER 13, 2026; WELCOMES SHAREHOLDER QUESTIONS AND DIALOGUE
11/11/2026
MINNEAPOLIS, Nov. 11, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV) ("PetVivo" or the “Company”), a biomedical device company focused on the commercialization of innovative medical devices and [...]
MD Logic Health x Blu Vitals Launch First Collaboration Product, Mag 9+, a Breakthrough Nine-Form Magnesium Complex
11/11/2026
Miami, FLORIDA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- MD Logic Health® is collaborating with Blu Vitals, its newest cobrand, to introduce Mag 9+, the first product from the partnership. Blu Vitals is a longevity-focused [...]
Major shareholder announcement - BlackRock, Inc.
11/11/2026
ANNOUNCEMENT NO. 328 11 November 2026 Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec A/S that, on 6 November 2026, BlackRock, Inc. increased [...]
Join Luma Named Cheapest Place to Buy Compounded Tirzepatide Online Among Seven Providers Compared for 2026
11/11/2026
Join Luma ranks most affordable in a seven-provider comparison, with compounded tirzepatide injections from $149 per month on qualifying prepaid plans and no separate membership fee BETHPAGE, N.Y., Nov. 11, 2026 (GLOBE [...]
Whitecap Care’s Autism First Joins National Integrated Therapy Provider
11/11/2026
WARRENTON, Va., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Whitecap Care , a leading provider of innovative healthcare services and dedicated to providing advanced, compassionate healthcare services that meet the evolving needs [...]
Channel Medsystems Announces Grant Support for an Investigator-Sponsored Clinical Study Evaluating Cerene® Cryotherapy for Women With Adenomyosis
11/11/2026
BERKELEY, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held medical technology company dedicated to raising the standard of care for women with heavy menstrual bleeding and [...]
Ballipinar Dental Clinic to Bring Oral Health Advice to UK Patients During Mouth Cancer Action Month
11/11/2026
As more than 11,000 people are diagnosed with mouth cancer in the UK each year, the Antalya-based dental clinic highlights overlooked warning signs ahead of its Newcastle and Middlesbrough patient events LONDON, Nov. 11 [...]
NEXGEL Announces Noteholder Participation in Strategic Recapitalization and Approximately $1.2 Million in New Capital Funding
11/11/2026
Approximately 95% of Outstanding Convertible Note Principal Committed to Conversion, Subject to Completion of a Strategic Merger Sequence LifeScience ™ Provides $732,000, Representing 61% of Approximately $1.2 Million [...]
Beeline Medicines Announces Presentation of Phase 2 Results of Afimetoran in Systemic Lupus Erythematosus at ACR Convergence 2026
11/11/2026
– All three afimetoran doses met the primary endpoint with a placebo-adjusted difference in SRI-4 response of more than 30 percentage points at Week 48 (p<0.001 for all doses) – – Secondary endpoints were [...]
23andMe Research Institute and Scripps Research Translational Institute, a division of Scripps Research, Partner to Bring Genetics-Based Recruitment to Alzheimer's Prevention Research
11/11/2026
Partnership pairs 23andMe Research Institute's consented research community with novel Scripps Research-led Alzheimer's prevention study PALO ALTO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute [...]
Tempest Therapeutics Exercises Option to License Senlang’s CD7-Targeted Lentiviral In Vivo CAR-T Platform Following Initial Phase 1 Results with Lead BCMA/GPRC5D Candidate
11/11/2026
-Tempest secures exclusive global rights outside China to a targeted lentiviral platform and portfolio of in vivo CAR-T candidates -Lead BCMA/GPRC5D dual-targeting in vivo CAR-T candidate evaluated in 13 patients with [...]
InnoCare Announces First Patient Dosed in Clinical Trial of Novel PSMA/ STEAP1 Bispecific ADC ICP-B381 in China
11/11/2026
BEIJING, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Akari Therapeutics Participates in Virtual Investor “What This Means” Segment Featuring Newly Appointed Chief Business Officer Vatnak Vat-Ho
11/11/2026
Discussion highlights Vat-Ho’s oncology business development experience, his decision to join Akari and the potential of the Company’s novel PH1 payload platform Watch the “What This Means” video here TAMPA, Fla. and [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum